Ming Yao | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Ming Yao is active.

Explore More

Publication

Featured researches published by Ming Yao.

Journal of Clinical Oncology | 2018

Lenvatinib plus checkpoint inhibitors in patients (pts) with advanced intrahepatic cholangiocarcinoma (ICC): Preliminary data and correlation with next-generation sequencing.

Jianzhen Lin; Weiwei Shi; Songhui Zhao; Jinwei Hu; Zheng Hou; Ming Yao; Gungwei Chrin; Jie Pan; Ke Hu; Lin Zhao; Milind Javle; Kai Wang; Haitao Zhao

Journal of Clinical Oncology | 2018

Genomic profiling of Chinese pancreatic adenocarcinoma and the implications for therapy.

Songzhu Yang; Linlin Qu; Yujie Feng; Jun Guo; William Lewis; Jicheng Yao; Yue Che; Weifeng Wang; Ming Yao

Journal of Clinical Oncology | 2018

Pan-cancer genomic features of PIK3CA/PTEN and clinical response to everolimus in Chinese population.

Guoling Lin; Zhang Xiao Chen; Yong Li; Yunsheng Qin; Zhen Lv; Tao Xiang; Yingcheng Lin; Cheng Zou; William Lewis; Honglin Guo; Jinwei Hu; Aodi Wang; Ming Yao

Journal of Clinical Oncology | 2018

Genomic feature differences in APC-mutant and wild-type colorectal cancer patients.

Jing Hu; Yun Guo; Jie Lin; Xiaojian Liu; Honglin Guo; Ruobing Ma; Yuan Zhang; Yu-An Dong; Weiwei Shi; Ming Yao

Journal of Clinical Oncology | 2018

Circulating tumor DNA analysis for osimertinib resistance Chinese NSCLC patients.

Weiguang Gu; Yong Li; Hongxi Hong; Bai Liu; Aodi Wang; Wenjin Liu; Shuo Mu; Ming Yao; Kai Wang

Journal of Clinical Oncology | 2018

Association analysis of the combination of tumor burden and PD-L1 expression and response to PD-1/L1 inhibitors in Chinese cancer patients.

Kunsong Li; Geng Tian; Senming Wang; William Lewis; Xiaodong Pan; XiaoWei Dong; Donglin Chen; Ming Yao; Kai Wang

Journal of Clinical Oncology | 2018

Pan-cancer genomic variation characteristics of CDKN2A/CDKN2B/CCND1 in Chinese patients.

Songfeng Yu; Qiyong Li; Lei Dai; Peng Zhao; Li Zhuang; Yigang Qian; Li Yang; Ming Wang; Yuandong Wang; Honglin Guo; Ruobing Ma; Ming Yao

Journal of Clinical Oncology | 2018

The pathway regulating RhoA activity to predict the survival of gastric cancers.

Jing Gao; Wenwen Huang; Shuo Mu; Songhui Zhao; Shuirong Zhang; Peng Zhang; Sai Ge; Zhongwu Li; Cheng Zhang; Ming Yao; Zhenzhen Liu; Kai Wang; Weiwei Shi; Lin Shen

Cancer Research | 2018

Abstract 3437: Genomic alterations, mutation burden, and microsatellite instability status of Chinese intrahepatic cholangiocarcinoma

Jingyu Cao; Bo Jiang; Zimin Liu; Weibin Shu; Lei Li; Han Yang; Hua Li; Zhiyu Xiao; Maolin Yan; Jie Lin; Siqin Liu; Peng Zhang; Milind Javle; Ming Yao; Kai Wang; Haitao Zhao

Cancer Research | 2018

Abstract 4607: G1/S transition-related gene mutations associated with survival of hepatocellular carcinoma patients

Bingyuan Zhang; Tianqiang Song; Pingzhou Yang; Songzhu Yang; Chao Guo; Lei Li; Shuang Ren; Maolin Yan; Weiyu Hu; Honglin Guo; Yongjian Zhang; Yanlin Li; Weifeng Wang; Kai Wang; Ming Yao

Explore More